Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Microbiology 151 (2005), 2133-2140; DOI  10.1099/mic.0.27849-0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brüssow, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brüssow, H.
Agricola
Right arrow Articles by Brüssow, H.
Microbiology 151 (2005), 2133-2140; DOI  10.1099/mic.0.27849-0
© 2005 Society for General Microbiology

Review

Phage therapy: the Escherichia coli experience

Harald Brüssow

Nestlé Research Centre, CH-1000 Lausanne 26 Vers-chez-les-Blanc, Switzerland

Correspondence
Harald Brüssow
harald.bruessow{at}rdls.nestle.com

Phages have been proposed as natural antimicrobial agents to fight bacterial infections in humans, in animals or in crops of agricultural importance. Phages have also been discussed as hygiene measures in food production facilities and hospitals. These proposals have a long history, but are currently going through a kind of renaissance as documented by a spate of recent reviews. This review discusses the potential of phage therapy with a specific example, namely Escherichia coli.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
T. K. Lu and J. J. Collins
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
PNAS, March 24, 2009; 106(12): 4629 - 4634.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
Y. D. Niu, T. A. McAllister, Y. Xu, R. P. Johnson, T. P. Stephens, and K. Stanford
Prevalence and Impact of Bacteriophages on the Presence of Escherichia coli O157:H7 in Feedlot Cattle and Their Environment
Appl. Envir. Microbiol., March 1, 2009; 75(5): 1271 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 J. Environ. Qual.Home page
M. R. McLaughlin and J. P. Brooks
EPA Worst Case Water Microcosms for Testing Phage Biocontrol of Salmonella
J. Environ. Qual., January 4, 2008; 37(1): 266 - 271.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
S. Zuber, C. Ngom-Bru, C. Barretto, A. Bruttin, H. Brussow, and E. Denou
Genome Analysis of Phage JS98 Defines a Fourth Major Subgroup of T4-Like Phages in Escherichia coli
J. Bacteriol., November 15, 2007; 189(22): 8206 - 8214.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
L.-T. Wu, S.-Y. Chang, M.-R. Yen, T.-C. Yang, and Y.-H. Tseng
Characterization of Extended-Host-Range Pseudo-T-Even Bacteriophage Kpp95 Isolated on Klebsiella pneumoniae
Appl. Envir. Microbiol., April 15, 2007; 73(8): 2532 - 2540.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2005 Society for General Microbiology.